# Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19

> **NCT04447534** · PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 191 (actual)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Chloroquine or hydroxychloroquine
- **DRUG:** zinc

## Key facts

- **NCT ID:** NCT04447534
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-23
- **Primary completion:** 2020-07-15
- **Final completion:** 2020-08-15
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2022-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04447534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04447534, "Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04447534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*